Recent Advances across Cancer Biomarkers - Genetic TOE

USD 250

* Required Fields

USD 250


Be the first to review this product

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across cancer biomarkers. The corresponding patent scenario is depicted along with the industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Biomarker assay, programmed death-1, PD-1, PD-1 ligand, PD-L1, gene signature assay, breast cancer recurrence, blood tests, colorectal cancer screening

Table of Contents

Recent Advances across Cancer Biomarkers - Genetic TOETrend OverviewTrends in Cancer BiomarkersApplications SummaryAnalysis of Disease-Specific Applications for Cancer BiomarkersOverview of Cancer Biomarker UtilitiesTechnology ProfilesNew Biomarker Assay for PD-L1Gene Signature Assay for Breast Cancer RecurrenceNovel Blood Test for Colorectal Cancer ScreeningStrategic PerspectivesAnalyst Insights on Cancer BiomarkersAppendixPatent ScenarioPatent ScenarioIndustry Interactions




Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.